Cargando…
A potential immunotherapy target for breast cancer: parenchymal and immune-stromal expression of the NLRP3 inflammasome pathway
BACKGROUND: The NOD-, LRR- and pyrin domain‑containing 3 (NLRP3) inflammasome is a critical component of the innate immune system. It has been known to play an important role in the carcinogenesis and prognosis of breast cancer patients. While the clinical evidence of the relationship between NLRP3...
Autores principales: | Zhu, Qian-mei, Li, Hui-xian, Ma, Pei-qing, Wu, Lin-xin, Wang, Tai-hang, Li, Wen-bin, Zhang, Lin, Yang, Xue, Kong, Xiangyi, Sun, Yu-lin, Yan, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685553/ https://www.ncbi.nlm.nih.gov/pubmed/38031068 http://dx.doi.org/10.1186/s12885-023-11609-4 |
Ejemplares similares
-
NLRP3 inflammasome in endothelial dysfunction
por: Bai, Baochen, et al.
Publicado: (2020) -
Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer
por: Ju, Mingyi, et al.
Publicado: (2020) -
NLRP3 Inflammasome and Inflammatory Diseases
por: Wang, Zheng, et al.
Publicado: (2020) -
Genetic Polymorphisms in Inflammasome-Dependent Innate Immunity among Pediatric Patients with Severe Renal Parenchymal Infections
por: Cheng, Chi-Hui, et al.
Publicado: (2015) -
Regulation of NLRP3 Inflammasome by Phosphorylation
por: Song, Nan, et al.
Publicado: (2018)